Sanofi SA at Goldman Sachs Global Healthcare Conference Transcript
Good evening, good morning, good afternoon, everyone, and thank you for joining us. My name is Keyur Parekh, and I cover Sanofi for Goldman Sachs. Dietmar, thank you so much for taking the time to join us in California. Unfortunately, I'm stuck in somewhat sunny London. So that's kind of the saving grace, but thank you again for making the trip. I appreciate it.
Dietmar, before we kind of go to Q&A, just (inaudible) of introduction for everybody listening in. Dietmar is the head of Global kind of Development and the Chief Medical Officer for Sanofi, having joined Sanofi about 2.5 years back.
Dietmar, I don't know if you want to make some opening comments on kind of your 2.5 years at Sanofi, how that's kind of progressed, the kind of changes you've made, what you see -- what excites you today before we get into specific stuff.
Yes, Great. Thanks for having me, first of all, and this is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |